Re-analysis of clinical trials recently made open access has confirmed the link between suicidal tendency and paroxetine, a member of the class of antidepressants known as SSRIs. The link had previously been suspected but was difficult to establish because the studies were not readily available. Toshi A Furukawa. BMJ 2004;329:626 (11 September). The letter concludes: "There is one clear lesson to be learnt. All clinical trials, not only those conducted by drug companies but all of them, must be reported in detail and made publicly available as soon as reasonably possible. Without such policy internationally, neither healthcare professionals nor consumers can make sufficiently informed decisions."
Posted by
Health Perspectives at 9/10/2004 02:17:00 AM.
The open access movement:
Putting peer-reviewed scientific and scholarly literature
on the internet. Making it available free of charge and
free of most copyright and licensing restrictions.
Removing the barriers to serious research.
I recommend the OA tracking project (OATP) as the best way to stay on top of new OA developments. You can read the OATP feed on a blog-like web page or subscribe to it by RSS, email, or Twitter. You can also help build the feed by tagging new developments you encounter.
